Abivax drops 16% despite positive news, investors remain skeptical
Abivax's stock falls 16% following news deemed positive by management.
Published 1j1 sourceupdated 17h
Lire en français
≈ 16s
The fact
Investors appear skeptical about the company's ability to deliver on its promises.
The stock remains volatile amid caution in the biotech sector.
Click the link to read an article on the topic: